The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.
 
Jane Bayani
Patents, Royalties, Other Intellectual Property - Ontario Institute for Cancer Reasearch
 
Elizabeth Kornaga
No Relationships to Disclose
 
Cheryl Crozier
No Relationships to Disclose
 
Gun Ho Jang
No Relationships to Disclose
 
Irina Kalatskaya
No Relationships to Disclose
 
Quang M Trinh
No Relationships to Disclose
 
Cindy Q Yao
Patents, Royalties, Other Intellectual Property - Ontario Institute for Cancer Research
 
Julie Livingstone
No Relationships to Disclose
 
Annette Hasenburg
No Relationships to Disclose
 
Dirk G Kieback
No Relationships to Disclose
 
Christos Markopoulos
No Relationships to Disclose
 
Luc Dirix
No Relationships to Disclose
 
Paul Christopher Boutros
Patents, Royalties, Other Intellectual Property - Holds patents on multiple biomarkers
 
Melanie Spears
Patents, Royalties, Other Intellectual Property - Ontario Institute for Cancer Research
 
Lincoln D. Stein
No Relationships to Disclose
 
Daniel Rea
No Relationships to Disclose
 
John Bartlett
Honoraria - Oncology Education
Consulting or Advisory Role - BioNTech; bioTheranostics; Insight Genetics; True North Therapeutics
Research Funding - Genoptix; MammaPrint; NanoString Technologies; Stratifyer GmbH
Patents, Royalties, Other Intellectual Property - John Bartlett currently has 7 pending patents: 1. Methods and Devices for Predicting Anthracycline Treatment PCT/CA2015/050660, 2. Method and Apparatus for Predicting Risk in Breast Cancer US62/085,416, 3. Methods and Devices for Predicting Anthracycline (Inst)